JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266234

Human SLC7A1 (CAT1) knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

SLC7A1 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 35 bp deletion in exon 3. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

View Alternative Names

ATRC1, Amino acid transporter cationic 1, CTR1_HUMAN, ERR, Ecotropic retroviral leukemia receptor homolog, Ecotropic retroviral receptor, Ecotropic retrovirus receptor homolog, HCAT1, High-affinity cationic amino acid transporter-1, REC1L, Slc7a1, Solute carrier family 7 (cationic amino acid transporter, y+ system) member 1, Solute carrier family 7 member 1, System Y+ basic amino acid transporter

2 Images
Sanger Sequencing - Human SLC7A1 (CAT1) knockout HEK-293T cell line (AB266234)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC7A1 (CAT1) knockout HEK-293T cell line (AB266234)

Allele-2 : 1 bp insertion in exon 3.

Sanger Sequencing - Human SLC7A1 (CAT1) knockout HEK-293T cell line (AB266234)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC7A1 (CAT1) knockout HEK-293T cell line (AB266234)

Allele-1 : 35 bp deletion in exon3

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 35 bp deletion in exon 3

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266234-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266234 Human SLC7A1 (CAT1) knockout HEK-293T cell line", "number":"AB266234-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266234-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266234-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266234-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266234 Human SLC7A1 (CAT1) knockout HEK-293T cell line", "number":"AB266234-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266234-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266234 Human SLC7A1 (CAT1) knockout HEK-293T cell line", "number":"AB266234-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266234-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266234 Human SLC7A1 (CAT1) knockout HEK-293T cell line", "number":"AB266234-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SLC7A1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CAT1 also known as cationic amino acid transporter 1 or SLC7A1 is an integral membrane protein that facilitates the uptake of cationic amino acids such as arginine lysine and ornithine. CAT1 is a member of the solute carrier family 7 and has a molecular mass of approximately 68 kDa. It expresses widely in various tissues with particularly high levels in the liver lung and skeletal muscle. As a transporter CAT1 plays an essential role in amino acid homeostasis by mediating amino acid transport across the cell membrane.
Biological function summary

CAT1 influences nitric oxide production by regulating arginine availability a substrate for nitric oxide synthase. By controlling amino acid imports it affects cellular signaling and metabolism. CAT1 does not function as part of a larger complex but interacts with other transporters to maintain cellular amino acid balance. CAT1's role extends to impacting cell proliferation as cationic amino acids are important for growing tissues.

Pathways

CAT1 has been implicated in the nitric oxide synthesis pathway where it contributes by sustaining intracellular arginine levels. This involvement is critical to vascular function and immune response regulation. CAT1 also participates in mTOR signaling by providing necessary amino acids like arginine which influence protein synthesis and cellular growth. In these pathways CAT1 connects with proteins such as mTOR and nitric oxide synthase assisting in integral cellular functions.

CAT1 links to cardiovascular conditions through its role in nitric oxide production which affects blood pressure regulation and endothelial function. Dysfunction or altered expression of CAT1 can lead to cardiovascular abnormalities due to impaired nitric oxide synthesis. CAT1 is also implicated in cancer as its impact on arginine availability affects cell proliferation and tumor growth. In this context CAT1 interacts with oncogenes and tumor suppressor proteins that modulate growth-related pathways.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com